Work that moves between the lab and the bedside, translating discovery into treatment
In the long and often quiet work of medical science, recognition sometimes arrives in forms that reach beyond the laboratory — and so it is with Professor Nick Gottardo, a Western Australian researcher whose decades of effort to improve survival and quality of life for children with brain cancer has earned him a finalist nomination for the 2026 Western Australian of the Year award. His work, supported by Cancer Council WA since 2016 through fellowships and grants, moves between bench and bedside in one of oncology's most challenging arenas. The nomination is a reminder that sustained, rigorous commitment to the most difficult problems — those measured in children's lives — eventually finds its way into broader human acknowledgment.
- Childhood brain cancer remains one of the most devastating diagnoses in medicine, and the researchers working against it do so in a field where progress is hard-won and rarely swift.
- Professor Gottardo's finalist nomination for Western Australian of the Year lifts his work from the specialist world of oncology into full public view, amplifying the stakes of pediatric cancer research at a time when medical funding is perpetually contested.
- Cancer Council WA's decade-long investment — fellowships, project grants, and a 2022 Cancer Researcher of the Year award — now finds public validation in this broader recognition, suggesting the organization's confidence in Gottardo was well placed.
- His international reputation as both researcher and clinician signals that the approaches developed in Western Australia are shaping how childhood brain cancer is understood and treated far beyond the state's borders.
- The finalist designation, while not yet the award itself, guarantees renewed attention to his work and to the families for whom that work carries the most immediate and personal weight.
Professor Nick Gottardo has been named a finalist for the 2026 Western Australian of the Year award — a recognition that draws public attention to his career-long effort to improve survival rates and quality of life for children diagnosed with brain cancer. The announcement was made by Cancer Council WA, which has supported his research for nearly a decade.
Gottardo is known internationally as both a researcher and a clinician, someone who moves between laboratory discovery and patient care. His focus on childhood brain cancer — among the most devastating diagnoses a family can face — has defined his professional life, driven not by abstraction but by the concrete goal of giving children better odds.
Cancer Council WA's support has been sustained and deliberate: a Research Fellowship from 2016 to 2019, followed by Research Project Grants in 2017, 2021, and 2024. In 2022, the organization named him Cancer Researcher of the Year, citing groundbreaking research and an unwavering commitment to advancing childhood cancer treatment. The current finalist nomination extends that recognition into the broader public sphere.
CEO Ashley Reid's statement of congratulations carries a sense of genuine investment — the feeling that resources directed toward Gottardo's work years ago are now bearing fruit in ways that reach well beyond any single grant. For Cancer Council WA, his recognition is also their own.
The Western Australian of the Year award is not given lightly, and a finalist nomination ensures that Gottardo's work will receive renewed attention at a moment when medical research funding is always under pressure. For families navigating a childhood brain cancer diagnosis, the public acknowledgment of the researchers working on their behalf carries a weight all its own.
Professor Nick Gottardo has been named a finalist for the 2026 Western Australian of the Year award, a recognition that places a spotlight on decades of work aimed at improving survival rates and quality of life for children diagnosed with brain cancer. The announcement comes from Cancer Council WA, which has been instrumental in supporting his research since 2016.
Gottardo's reputation extends well beyond Western Australia. He is known internationally as both a researcher and clinician—someone who moves between the laboratory and the bedside, translating discoveries into treatments that reach actual patients. His focus on childhood brain cancer, one of the most devastating diagnoses a family can receive, has shaped the direction of his entire career. The work is not abstract; it is driven by the concrete goal of giving children better odds and better outcomes.
The organization's backing of his research has been sustained and substantial. Between 2016 and 2019, Cancer Council WA provided him with a Research Fellowship, the kind of foundational support that allows a scientist to pursue ambitious questions without the constant pressure of grant deadlines. Beyond that, the council awarded him Research Project Grants in 2017, 2021, and 2024—a pattern of investment that suggests confidence in both the researcher and the direction of his work.
In 2022, Cancer Council WA had already recognized Gottardo's contributions by naming him Cancer Researcher of the Year. That award acknowledged what the organization described as groundbreaking research and an unwavering commitment to advancing childhood cancer treatment and care. The finalist nomination for Western Australian of the Year represents a step further—recognition at a level that extends beyond the medical and scientific community into broader public acknowledgment of his impact.
What makes this recognition significant is not just the honor itself, but what it signals about the value placed on sustained, rigorous work in a field where progress often comes slowly and at great cost. Childhood brain cancer remains one of the most challenging areas of oncology. The fact that Gottardo's work has drawn international attention suggests that the approaches he and his team have developed are contributing meaningfully to how the disease is understood and treated globally.
Cancer Council WA's statement of congratulations, delivered by CEO Ashley Reid, frames the finalist recognition as a validation of the organization's own commitment to supporting this research. There is genuine satisfaction in the words—the sense that an investment made years ago is now bearing fruit in ways that extend beyond any single grant or fellowship. The council sees itself as part of Gottardo's journey, and his recognition reflects well on the choices they made about where to direct resources.
The Western Australian of the Year award itself recognizes individuals who have made extraordinary contributions to their state and, by extension, to the broader community. For a cancer researcher to be considered at that level speaks to how deeply his work has penetrated public consciousness and how significant his impact is understood to be. It is not a prize given lightly, and it is not given to researchers whose work remains confined to academic journals.
What happens next remains to be seen. The finalist designation does not guarantee the award itself, but it does ensure that Gottardo's work will receive additional public attention at a moment when funding for medical research is always contested and never sufficient. For families facing a childhood brain cancer diagnosis, the recognition of the researchers working on their behalf carries its own kind of weight.
Citações Notáveis
His work continues to improve outcomes for children diagnosed with brain cancer in Western Australia and around the world— Cancer Council WA
A Conversa do Hearth Outra perspectiva sobre a história
What makes a cancer researcher stand out enough to be considered for a state-level award like this?
It's not just the papers published or the grants won. It's the combination of rigorous science, clinical impact, and the ability to move between the lab and patient care. Gottardo does all three. He's not just theorizing about brain cancer—he's treating children with it and using what he learns to improve the science.
Cancer Council WA has been funding his work for a decade now. That's a long commitment. What does that kind of sustained support actually enable?
It allows a researcher to think in decades, not grant cycles. You can pursue questions that take years to answer. You can build a team. You can take risks on ideas that might not pan out immediately because you're not constantly scrambling for the next funding round. That stability is rare and precious.
Childhood brain cancer is a relatively small field compared to, say, breast cancer or lung cancer. Does that make the work harder or easier?
Harder, in almost every way. Fewer patients means smaller datasets, less funding attention, less pharmaceutical industry interest. But it also means the researchers who do work in the field are often driven by something deeper than career advancement. They're there because the problem matters to them.
The award recognizes him as a Western Australian of the Year finalist. Does geography matter in science?
Not for the science itself, but it matters for how communities understand their own capacity. When a state recognizes that one of its own is doing world-class work, it sends a signal about what's possible locally. It also matters for recruitment—talented people want to work where their work is valued.
What does this recognition mean for families dealing with a childhood brain cancer diagnosis right now?
Directly, it might mean better treatment options down the line, because this kind of public recognition often translates into continued funding and attention. But there's also something immediate in it—the knowledge that serious people are working seriously on the problem, that resources are being directed toward it, that progress is being made.